Interaction of soybean agglutinin with leukemic T-cells and its use for their in vitro separation from normal lymphocytes by lectin-affinity chromatography

Biomedical Chromatography

Volumn 17, Issue 4, 2003, Pages 239-249

  Bakalova, R ^a   Ohba, H ^a  

^a Inst Struct Engineering Materials   (Japan)

Author keywords

Acute lymphoblastic leukemia; Fraction of cells; Lectin affinity chromatography; Soybean agglutinin

Indexed keywords

AFFINITY CHROMATOGRAPHY; CELL CULTURE; COLUMN CHROMATOGRAPHY; DISEASES; FLUORESCENCE; PROTEINS;

ACUTE LYMPHOBLASTIC LEUKAEMIAS; AFFINITY COLUMN; FLUORESCENT MICROSCOPY; FRACTION OF CELL; IN-VITRO; LECTIN AFFINITY; LECTIN-AFFINITY CHROMATOGRAPHY; LEUKEMIC CELLS; MOBILE PHASIS; SOYBEAN AGGLUTININS;

T-CELLS;

ACETIC ACID; BIOCHEMICAL MARKER; FLUORESCEIN ISOTHIOCYANATE; LECTIN; N ACETYLGALACTOSAMINE; SEPHAROSE; SOYBEAN AGGLUTININ;

ACUTE LYMPHOBLASTIC LEUKEMIA; AFFINITY CHROMATOGRAPHY; ANALYTIC METHOD; ARTICLE; CELL FRACTIONATION; CELL SPECIFICITY; CELL TYPE; CELL VIABILITY; COLUMN CHROMATOGRAPHY; CONCENTRATION RESPONSE; CONTROLLED STUDY; COVALENT BOND; CYTOTOXICITY; DRUG CONJUGATION; ELECTROPHORETIC MOBILITY; ELUTION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; FLUORESCENT ANTIBODY TECHNIQUE; FLUOROMETRY; GEL; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; LEUKEMIA CELL LINE; MOLECULAR INTERACTION; MOLECULAR PROBE; SEPARATION TECHNIQUE; T LYMPHOCYTE; TARGET CELL;

GLYCINE MAX;

EID: 0038725091     PISSN: 02693879     EISSN: None     Source Type: Journal    
DOI: 10.1002/bmc.218     Document Type: Article

References (36)

1. Boldt DH. Chronic lymphocytic leukemia: demonstration of cell surface structural heterogeneity by lectin affinity chromatography of cell extracts. Leukemia Research 1982; 6(4): 499.
2. Bouckaert J, Hamelryck T, Wyns L and Loris R. Novel structures of plant lectins and their complexes with carbohydrates. Current Opinion in Structural Biology 1999; 9: 572.
3. Chay CH and Pienta KJ. Evidence for lectin signaling to the nuclear matrix: cellular interpretation of the glycocode. Journal of Cell Biochemistry 2000; 35: S123.
4. Dahms NM and Hart GW. Influence of quaternary structure on glycosylation. Differential subunit association affects the site-specific glycosilation of the common beta-chain from Mac-1 and LFA-1. Journal of Biological Chemistry 1986; 261(28): 13186.
5. Fischer J, Klein PJ and Uhlenbruck G. Detection and characterization of glycoconjugates in normal and malignant tissues by lectins. Acta Histochemica 1988(Suppl.); 86: 191.
6. Forsberg LS and Macher BA. Lectin affinity fractionation of asparagine-linked oligosaccharides from normal human and chronic leukemic leukocytes. Cancer Biochemistry and Biophysics 1987; 9: 155.
7. Gabius HJ. Endogenous lectins in tumors and their possible importance in the diagnosis and therapy of cancers. Onkologie 1989; 12(4): 175.
8. Gabius HJ. Concepts of tumor lectinology. Cancer Investigations 1997; 15: 454.
9. Gabius H. Probing the cons and pros of lectin-induced immunomodulation: Case studies for the mistletoe lectin and galectin-1. Biochimie 2001; 83: 659.
10. Gabius HJ, Engelhard R and Cramer F. Endogenous tumor lectins: a new class of tumor markers and targets for therapy? Medical Hypotheses 1985; 18(1): 47.
11. Gabius HJ, Engelhard R and Cramer F. Endogenous tumor lectins: overview and perspectives. Anticancer Research 1986; 6(4): 573.
12. Gabius HJ, Vehmeyer K, Gabius S and Nagel GE. Clinical application of various plant and endogenous lectins to leukemia. Blood 1988; 56: 147.
13. Hozumi M. Fundamentals of chemo-differentiation therapy of myeloid leukemia. Anticancer Research 1994; 14(3A): 1177.
14. Itokazu M, Tan A and Tanaka S. Separation of osteoclasts by lectin affinity chromatography. Nippon Seikeigeka Gakkai Zasshi 1991; 65: 762.
15. Kemmner W, Moldenhauer G, Schlag P and Brossmer R. Separation of tumor cells from a suspension of dissociated human colorectal carcinoma tissue by means of monoclonal antibody-coated magnetic beads. Journal of Immunological Methods 1992; 147: 197.
16. Killion JJ and Kollmorgen GM. Isolation of immunogenic tumor cells by cell-affinity chromatography. Nature 1976; 259: 674.
17. Lee N, Wang WC and Fukuda M. Granulocytic differentiation of HL-60 cells is associated with increase of poly-N-acetyllactosamine in Asn-linked oligosaccharides attached to human lysosomal membrane glycoproteins. Journal of Biological Chemistry 1990; 265(33), 20476.
18. Marmont AM. Stem cell transplantation for severe autoimmune diseases: progress and problems. Haematologica 1998; 83(8): 733.
19. Misra RR, Pinsky PF and Srivastava S. Prognostic factors for hematologic cancers. Hematology and Oncology Clinics of North America 2000; 14(4): 907.
20. Mody R, Joshi S and Chaney W. Use of lectins as diagnostic and therapeutic tools for cancer. Journal of Pharmacology and Toxicology Methods 1995; 33: 1.
21. Moriwaki S, Ohba H, Nakamura O, Sallay I, Suzuki M, Tsubouchi H, Yamasaki N and Itoh K. Biological activities of the lectin, abrin-a, against human lymphocytes and cultured leukemic cell lines. Journal of Hematotherapy and Stem. Cell Research 2000; 9: 47.
22. Neame PB, Soamboonsrup P, Quigley JG and Pewarchuck W. The use of monoclonal antibodies and immune markers in the diagnosis, prognosis, and therapy of acute leukemia. Transfusion Medicine Review 1994; 8(1): 59.
23. Ohba H, Bakalova R, Moriwaki S and Nakamura O. Fractionation of normal and leukemic T-cells by lectin-affinity column chromatography. Cancer Letters 2002; 184: 207.
24. Pereira MEA and Kabat EA. A versatile immunoadsorbent capable of binding lectins of various specificities and its use for the separation of cell populations. Journal of Cell Biology 1979; 82: 185.
25. Petros WP and Evans WE. Pharmacokinetics and pharmacodynamics of anticancer agents: contributions of the therapy of childhood cancer. Pharmacotherapy 1990; 10(5): 313.
26. Reading CL, Hickey CM and Yong WB. Analysis of cell surface glycoprotein changes related to hematopoetic differentiation. Journal of Cell Biochemistry 1988; 37(1): 21.
27. Reed CJ. Apoptosis and cancer: strategies for integrating programmed cell death. Seminars in Hematology 2000; 37((4): Suppl.): 9.
28. Roth J, Zuber C, Komminoth P, Sata T, Li WP and Heitz PU. Applications of immunogold and lectin-gold labeling in tumor research and diagnosis. Histochemistry and Cell Biology 1996; 106(1): 131.
29. Sallay I, Moriwaki S, Nakamura O, Yasuda S, Kimura M, Yamasaki N, Itoh K and Ohba H. Interaction of the hemolytic lectin, CEL-III, with cultured human leukemic cell lines. Journal of Hematotherapy and Stem Cell Research 2000; 9: 877.
30. Santos GW. Problems and strategies for bone marrow transplantation in acute leukemia and chromic myelogenous leukemia. Cancer Detection and Prevention 1988; 12((1-6)): 589.
31. Santos GW. Bone marrow transplantation in hematologic malignancies. Cancer 1990; 65(Suppl.): 786.
32. Solary E, Droin N, Bettaieb A, Corcos L, Dimanche-Boitrel MT and Garrido C. Positive and negative regulation of apoptotic pathways by cytotoxic agents in hematological malignancies. Leukemia 2000; 14(10): 1833.
33. Sweetenham JW. The importance of dose and schedule in cancer chemotherapy: haematological cancer. Anticancer Drugs 1995; 6(Suppl.): 7.
34. Vaickus L, Ball ED and Foon KA. Immune markers in hematologic malignancies. Critical Reviews in Oncology and Hematology 1991; 11(4): 267.
35. Volman GN, Narasimhan S and Letarte M. Analysis of asparagine-linked oligosaccharide structures of chronic lymphocytic leukemia cells. Molecular Immunology 1987; 24(8): 871.
36. Wigzell H, Sundqvist KG and Yoshida T. Separation of cells according to surface antigens by the use of antibody-coated columns. Fractionation of cells carrying immunoglobulins and blood group antigen. Scandinavian Journal of Immunology 1972; 1: 75.